Express Scripts Exclusions Target 25 Drug Classes

Slides:



Advertisements
Similar presentations
What You Wanted to Know About Formularies Emmanuelle Mirsakov Pharm.D. Candidate 2007 USC School Of Pharmacy.
Advertisements

Preparing for What’s on the Prescription Drug Benefit Horizon Brenda Motheral, PhD Senior Vice President Research & Product Management.
CITY OF LAREDO HUMAN RESOURCES DEPARTMENT By: Daniel E. Migura Jr. HEALTH & BENEFITS FUND.
Generic Substitution Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Paying Less By Purchasing Smarter Gerard Anderson, PhD Professor Johns Hopkins University.
PROPRIETARY AND CONFIDENTIAL Internal Strategic Pharmacy Programs Placemat Background 1  Prescriptions are the most frequently used health care benefit,
1 Variation in Medicare Part D Prescription Drug Plan Benefits, 2006 Leslie M. Greenwald, Ph.D. Principal Scientist RTI, International.
Lehman Brothers 9th Annual Global Healthcare Conference March 8, 2006.
Promoting high quality, cost effective drug therapy throughout the Military Health System Industry Teleforum August 2010 P&T By Dr. Jeremy Briggs PharmD,
Controlling the Bottom Line. What is specialty pharmacy? Wide variations in definitions Compounded drugs Biotech drugs Expensive drugs Workman’s Compensation.
2007 Drug Trend Brian Seiz, PharmD Express Scripts.
Avalere Health LLC | The intersection of business strategy and public policy Part D Plans and Specialty Products Presented by Lovisa Gustafsson.
Confidential and Proprietary Information © 2014 Express Scripts Holding Company. All Rights Reserved. 1 Confidential and Proprietary Information © 2014.
Drug Formulary Development & Management
Pharmacy Benefit Management (PBM) 101
Why are the Costs of Medications Increasing and What Can Be Done About It? William H. Shrank, M.D., M.S.H.S. April 15, 2016.
Source: Kaiser Family Foundation analysis of National Health Expenditure (NHE) Historical ( ) data from Centers for Medicare and Medicaid Services,
Rx carve Out Proposal Board Meeting April4, 2016.
Formulary Manufacturer Contracting Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
Integrated Research Methodology
Managed Care Models: The Benefit vs. Cost Balance
BUSI 406 Principles of Marketing: Second Exam Review
Pharmacy & Therapeutics Committee
Health Strategies Group
How is WEA Trust Reclaiming Healthcare?
Drug Management Updates
Pharmaceutical Spending the United States
Health Strategies Group
Cost Effective Studies
The Basics of Pharmacy Benefit Management (PBM)
Health Strategies Group
Pharmacy & Therapeutics Committee
Health Strategies Group
Health Strategies Group
2018 and Beyond: Outlook and Turning Points
An Increasing Demand for Prescription Drugs Drives Profitability
Exhibit 9.17 Among Large Firms Whose Plan with the Largest Enrollment Covers Specialty Drugs, Percentage of Firms that Use the Following Strategies to.
Combined Albertsons–Rite Aid Projects $83 Billion in 2018 Revenue
Health Strategies Group
Health Strategies Group
Budget Proposals Have Myriad Effects on the Industry
Combined Cigna-Express Scripts to Move toward Total Healthcare Company
Goldman Sachs 26th Annual Global Healthcare Conference
Banc of America Health Care Conference 2005
Most leaders support competitive bidding for medical equipment prices and negotiation of drug prices by Medicare. “Medicare is the largest payer for health.
Health Strategies Group
Health Strategies Group
Health Strategies Group
Anticoagulants: System-Level Contracting
2006 Healthcare Conference
Health Strategies Group
Health Strategies Group
Health Strategies Group
Combined Cigna-Express Scripts to Move toward Total Healthcare Company
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Concerned about high Rx costs?
Health Strategies Group
2018 Public Sector HealthCare Roundtable
Medicare Rx Legislation: Implications for PBMs
Direct Medicare Price Negotiation is Good for Payers
Health Strategies Group
Jan Berger, M.D., M.J. Senior Vice President Chief Medical Officer
Pharmacy – Fully Insured versus Self Funding
Pharmacy & Therapeutics Committee
The Rx for Rx Savings Breaking the Status Quo!
Ryan Czado, PharmD, MBA Director of Pharmacy Solutions
Formulary Manufacturer Contracting
Drug Formulary Development & Management
9 out of every 10 prescriptions written in the U. S
Pharmacy & Therapeutics Committee
Presentation transcript:

Express Scripts Exclusions Target 25 Drug Classes 12/5/2018 Health Strategies Group Author/Artist Express Scripts Exclusions Target 25 Drug Classes Express Scripts indicated that rebates, along with lower list prices, drove its exclusion decisions. 22 With the addition of the 48 new exclusions, the total number of Express Scripts exclusions increase to 242 for 2019. Have low-cost generic alternatives, even when brand drugs include rebates, the generic drugs have a better value 12 11 10 9 Instances of brand-to-brand competition, where drugs have the same active ingredient, but the excluded drug has a higher net cost Specialty drugs with a lower-cost brand or biosimilar alternative and a lower list price Drugs that are multisource brands with direct generic equivalents. Short-term therapies, such a topical creams and ophthalmic treatments . Source: Express Scripts, 2019 National Preferred Formulary: Better Access Better Value. Retrieved from http://lab.express-scripts.com/lab/insights/drug-options/2019-national-preferred-formulary-better-access-better-value. Accessed August 8, 2018; Health Strategies Group, Leading Health Plans and PBMs, August 2018.